Boekholdt, S. Matthijs

Impact of high-dose atorvastatin therapy and clinical risk factors on incident aortic valve stenosis in patients with cardiovascular disease (from TNT, IDEAL, and SPARCL)

Arsenault, B. J., Boekholdt, S. M., Mora, S., DeMicco, D. A., Bao, W., Tardif, J.-C., Amarenco, P., Pedersen, T., Barter, P., & Waters, D. D. (2014) · The American Journal of Cardiology

Lipoproteins and Cardiovascular HealthCardiac Valve Diseases and Treatments

Cited by 36

apoB/apoA-I ratio and lp(a) associations with aortic valve stenosis incidence: insights from the EPIC-norfolk prospective population study

Zheng, K. H., Arsenault, B. J., Kaiser, Y., Khaw, K., Wareham, N. J., Stroes, E. S. G., & Boekholdt, S. M. (2019) · Journal of the American Heart Association

Lipoproteins and Cardiovascular HealthCardiac Valve Diseases and Treatments

Cited by 32

Is Cholesteryl Ester Transfer Protein Inhibition an Effective Strategy to Reduce Cardiovascular Risk?: CETP as a Target to Lower CVD Risk: Suspension of Disbelief?

Hovingh, G. K., Ray, K. K., & Boekholdt, S. M. (2015) · Circulation

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 31

Non‐HDL cholesterol vs. Apo B for risk of coronary heart disease in healthy individuals: the EPIC‐Norfolk prospective population study

Sondermeijer, B. M., Rana, J. S., Arsenault, B. J., Shah, P. K., Kastelein, J. J. P., Wareham, N. J., Boekholdt, S. M., & Khaw, K. (2013) · European Journal of Clinical Investigation

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 30

Leisure time physical activity is associated with improved diastolic heart function and is partly mediated by unsupervised quantified metabolic health

Klarenberg, H., van der Velde, J. H., Peeters, C. F., Dekkers, I. A., de Mutsert, R., Jukema, J. W., Rosendaal, F. R., Leiner, T., Froeling, M., Jorstad, H., et al. (2024) · BMJ Open Sport & Exercise Medicine

Cardiovascular Function and Risk FactorsPhysical Activity and Health

Cited by 4